Author:
Guydish Joseph,McCuistian Caravella,Hosakote Sindhushree,Le Thao,Masson Carmen L.,Campbell Barbara K.,Delucchi Kevin
Abstract
Abstract
Background
Smoking prevalence is high among people in substance use disorder (SUD) treatment, and program interventions to address smoking are often complex and lengthy. This cluster-randomized trial tested whether a brief multi-component intervention impacted tobacco outcomes among staff and clients.
Methods
Seven SUD treatment programs were randomly assigned to the multi-component intervention or to waitlist control. The 6-month intervention included a leadership motivation assessment, program incentives, 4 staff training sessions and a leadership learning community session. Survey data were collected from staff and clients at pre- and post-intervention. Outcomes were first compared across condition (intervention vs waitlist control), and then examined pre- to post-intervention with condition collapsed.
Results
Staff in the intervention (n = 48) and control conditions (n = 26) did not differ at post-intervention on smoking prevalence, self-efficacy to help clients quit, or practices used to help clients quit smoking. Intervention clients (n = 113) did not differ from controls (n = 61) in smoking prevalence or receipt of tobacco services. Pre-post comparisons collapsed across condition showed a decrease in client and staff smoking prevalence, which could not be attributed to the intervention, and a decrease in client receipt of cessation medication.
Conclusion
The brief multi-component intervention did not support changes in smoking prevalence or in tobacco-related services received by clients. Other intervention features are needed to reduce smoking among SUD clients.
Trial registration
Randomization occurred at the program level and outcomes measured are program-level measures. Accordingly, the trial is not registered.
Funder
Tobacco-Related Disease Research Program
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Health Policy
Reference54 articles.
1. Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco product use among adults - United States, 2020. MMWR Morb Mortal Wkly Rep. 2022;71(11):397–405. https://doi.org/10.15585/mmwr.mm7111a1.
2. U.S. Department of Health and Human Services. United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. In Smoking Cessation: A Report of the Surgeon General. Washington (DC); 2020.
3. Weinberger AH, Gbedemah M, Wall MM, Hasin DS, Zvolensky MJ, Goodwin RD. Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002–14: emerging disparities in vulnerable populations: cigarette use and substance use disorders. Addiction. 2018;113(4):719–28. https://doi.org/10.1111/add.14082.
4. Han B, Volkow ND, Blanco C, Tipperman D, Einstein EB, Compton WM. Trends in prevalence of cigarette smoking among US adults with major depression or substance use disorders, 2006–2019. JAMA. 2022;327(16):1566–76. https://doi.org/10.1001/jama.2022.4790.
5. Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Rockville: Center for Behavioral Health Statistics and Quality, SAMHSA; 2021. Retrieved from https://www.samhsa.gov/data. Accessed 29 Aug 2022.